Data-independent proteomic screen identifies novel tamoxifen agonist that mediates drug resistance.

A label-free quantitative variation of the recently developed data-independent shotgun proteomic method precursor acquisition independent from ion count (PAcIFIC) was used to identify novel proteins implicated in cancer progression and resistance. Specifically, this screen identified the pro-metastatic protein anterior gradient 2 (AGR2) as significantly up-regulated in tamoxifen-treated cells. Highlighting the need for direct proteome profiling methods like PAcIFIC, neither data-dependent gas-phase fractionation nor a transcriptomic screen detected AGR2 protein/transcript at significantly up-regulated levels. Further cell-based experiments using human cancer cell lines and in vivo xenografts confirmed the PAcIFIC hypothesis that AGR2 is up-regulated in MCF-7 cells post tamoxifen treatment and that it is implicated in drug resistance mediation.

[1]  Ruedi Aebersold,et al.  A microcapillary trap cartridge-microcapillary high-performance liquid chromatography electrospray ionization emitter device capable of peptide tandem mass spectrometry at the attomole level on an ion trap mass spectrometer with automated routine operation. , 2003, Rapid communications in mass spectrometry : RCM.

[2]  R. Aebersold,et al.  Approaching complete peroxisome characterization by gas‐phase fractionation , 2002, Electrophoresis.

[3]  Ken Chen,et al.  Recurring mutations found by sequencing an acute myeloid leukemia genome. , 2009, The New England journal of medicine.

[4]  R. Schiff,et al.  Resistance to endocrine therapy in breast cancer: exploiting estrogen receptor/growth factor signaling crosstalk. , 2006, Endocrine-related cancer.

[5]  Kay Dickersin,et al.  Shaping the future of biomarker research in breast cancer to ensure clinical relevance , 2007, Nature Reviews Cancer.

[6]  J. Winstanley,et al.  The metastasis-associated anterior gradient 2 protein is correlated with poor survival of breast cancer patients. , 2009, The American journal of pathology.

[7]  A. Balmain,et al.  Guidelines for the welfare and use of animals in cancer research , 2010, British Journal of Cancer.

[8]  J. Yates,et al.  An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database , 1994, Journal of the American Society for Mass Spectrometry.

[9]  R. Wilson,et al.  Cancer genome sequencing: a review. , 2009, Human molecular genetics.

[10]  Soyoung Ryu,et al.  Comparison of a Label-Free Quantitative Proteomic Method Based on Peptide Ion Current Area to the Isotope Coded Affinity Tag Method , 2008, Cancer informatics.

[11]  J. G. Cory,et al.  Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. , 1991, Cancer communications.

[12]  Anoop Kumar,et al.  Molecular Basis for the Nerve Dependence of Limb Regeneration in an Adult Vertebrate , 2007, Science.

[13]  Zheng Wang,et al.  The adenocarcinoma-associated antigen, AGR2, promotes tumor growth, cell migration, and cellular transformation. , 2008, Cancer research.

[14]  S. Langdon,et al.  Targeting the EGF receptor in ovarian cancer with the tyrosine kinase inhibitor ZD 1839 (‘Iressa’) , 2002, British Journal of Cancer.

[15]  Andrew H. Thompson,et al.  Tandem mass tags: a novel quantification strategy for comparative analysis of complex protein mixtures by MS/MS. , 2003, Analytical chemistry.

[16]  P. Rudland,et al.  Increased expression of anterior gradient-2 is significantly associated with poor survival of prostate cancer patients , 2007, Prostate Cancer and Prostatic Diseases.

[17]  L. De Cecco,et al.  Clusterin: a potential target for improving response to antiestrogens. , 2008, International journal of oncology.

[18]  Ruedi Aebersold,et al.  High-throughput generation of selected reaction-monitoring assays for proteins and proteomes , 2010, Nature Methods.

[19]  T. Fehm,et al.  Breast cancer proteomics by laser capture microdissection, sample pooling, 54‐cm IPG IEF, and differential iodine radioisotope detection , 2006, Electrophoresis.

[20]  Gang Wu,et al.  Correlation between mRNA and protein abundance in Desulfovibrio vulgaris: a multiple regression to identify sources of variations. , 2006, Biochemical and biophysical research communications.

[21]  Matthias Mann,et al.  A Dual Pressure Linear Ion Trap Orbitrap Instrument with Very High Sequencing Speed* , 2009, Molecular & Cellular Proteomics.

[22]  D. Goodlett,et al.  Faster, quantitative, and accurate precursor acquisition independent from ion count. , 2011, Analytical chemistry.

[23]  J. Yates,et al.  Large-scale analysis of the yeast proteome by multidimensional protein identification technology , 2001, Nature Biotechnology.

[24]  David E. Misek,et al.  Discordant Protein and mRNA Expression in Lung Adenocarcinomas * , 2002, Molecular & Cellular Proteomics.

[25]  S. Shaffer,et al.  Characterization of an improved electrodynamic ion funnel interface for electrospray ionization mass spectrometry. , 1999, Analytical chemistry.

[26]  P. Rudland,et al.  Significance of the metastasis-inducing protein AGR2 for outcome in hormonally treated breast cancer patients , 2006, British Journal of Cancer.

[27]  Minetta C. Liu,et al.  Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling , 2003, Oncogene.

[28]  T. Hupp,et al.  The Barrett’s Antigen Anterior Gradient-2 Silences the p53 Transcriptional Response to DNA Damage* , 2004, Molecular & Cellular Proteomics.

[29]  Ljiljana Paša-Tolić,et al.  Identification of a Putative Protein Profile Associated with Tamoxifen Therapy Resistance in Breast Cancer*S⃞ , 2009, Molecular & Cellular Proteomics.

[30]  J. Smyth,et al.  Altered ErbB receptor signaling and gene expression in cisplatin-resistant ovarian cancer. , 2005, Cancer research.

[31]  Samuel I. Miller,et al.  Genome-specific gas-phase fractionation strategy for improved shotgun proteomic profiling of proteotypic peptides. , 2008, Analytical chemistry.

[32]  Tom Royce,et al.  A comprehensive catalogue of somatic mutations from a human cancer genome , 2010, Nature.

[33]  Michael J MacCoss,et al.  Dual-pressure linear ion trap mass spectrometer improving the analysis of complex protein mixtures. , 2009, Analytical chemistry.

[34]  M. Mann,et al.  Stable Isotope Labeling by Amino Acids in Cell Culture, SILAC, as a Simple and Accurate Approach to Expression Proteomics* , 2002, Molecular & Cellular Proteomics.

[35]  Kelvin H Lee,et al.  A comparison of the consistency of proteome quantitation using two‐dimensional electrophoresis and shotgun isobaric tagging in Escherichia coli cells , 2005, Electrophoresis.

[36]  A. H. Drummond,et al.  Aminopeptidase inhibition as a targeted treatment strategy in myeloma , 2009, Molecular Cancer Therapeutics.

[37]  Qing‐Yu He,et al.  Synergistic effects of retinoic acid and tamoxifen on human breast cancer cells: proteomic characterization. , 2007, Experimental cell research.

[38]  A. Verkman,et al.  Evidence for phosphorylation of serine 753 in CFTR using a novel metal‐ion affinity resin and matrix‐assisted laser desorption mass spectrometry , 1997, Protein science : a publication of the Protein Society.

[39]  R. Aebersold,et al.  A statistical model for identifying proteins by tandem mass spectrometry. , 2003, Analytical chemistry.

[40]  Samuel I. Miller,et al.  Precursor acquisition independent from ion count: how to dive deeper into the proteomics ocean. , 2009, Analytical chemistry.

[41]  K. Parker,et al.  Multiplexed Protein Quantitation in Saccharomyces cerevisiae Using Amine-reactive Isobaric Tagging Reagents*S , 2004, Molecular & Cellular Proteomics.

[42]  M. Stratton,et al.  The cancer genome , 2009, Nature.

[43]  M. Gleave,et al.  Anticlusterin treatment of breast cancer cells increases the sensitivities of chemotherapy and tamoxifen and counteracts the inhibitory action of dexamethasone on chemotherapy-induced cytotoxicity , 2007, Breast Cancer Research.

[44]  G A Anderson,et al.  An ion funnel interface for improved ion focusing and sensitivity using electrospray ionization mass spectrometry. , 1998, Analytical chemistry.

[45]  Huamin Wang,et al.  Anterior gradient 2 is expressed and secreted during the development of pancreatic cancer and promotes cancer cell survival. , 2008, Cancer research.

[46]  E. Petty,et al.  High SEPT9_v1 expression in human breast cancer cells is associated with oncogenic phenotypes. , 2007, Cancer research.